Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-102290
Filing Date
2025-10-27
Accepted
2025-10-27 06:31:20
Documents
7

Document Format Files

Seq Description Document Type Size
1 DFAN14A tm2529507d2_dfan14a.htm DFAN14A 32406
2 GRAPHIC tm2529507d2_dfan14aimg001.jpg GRAPHIC 42008
3 GRAPHIC tm2529507d2_dfan14aimg002.jpg GRAPHIC 135865
4 GRAPHIC tm2529507d2_dfan14aimg003.jpg GRAPHIC 175312
5 GRAPHIC tm2529507d2_dfan14aimg004.jpg GRAPHIC 181741
6 GRAPHIC tm2529507d2_dfan14aimg005.jpg GRAPHIC 181567
7 GRAPHIC tm2529507d2_dfan14aimg006.jpg GRAPHIC 21806
  Complete submission text file 0001104659-25-102290.txt   1037010
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 3020 CALLAN ROAD SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Subject) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-39321 | Film No.: 251417365
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)